General form of registration statement for all companies including face-amount certificate companies

Balance Sheets

v3.20.4
Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Dec. 31, 2018
Current assets      
Cash $ 6,214,337 $ 6,835 $ 85,102
Deferred offering costs 42,580
Total current assets 6,256,917 6,835 85,102
Acquired patents, net 17,130 19,836 23,443
Total assets 6,274,047 26,671 108,545
Current liabilities      
Accounts payable & accrued interest 800,219 730,309 277,556
Accrued offering costs 42,580
Unreimbursed Expenses 138,009 11,626 30,889
Advance from related party/shareholder 635,154 635,154 420,154
Total current liabilities 1,615,962 1,377,089 728,599
Related party payable 9,500,000
Total liabilities 1,615,962 1,377,089 10,228,599
Stockholders' equity (deficit)      
Common stock, $0.001 par value; 100,000,000 shares authorized; 11,970,185 and 8,458,048 shares issued and outstanding as of September 30, 2020, December 31, 2019 and December 31, 2018, respectively 11,970 8,458 203
Preferred stock value  
Additional paid-in capital 32,572,042 25,853,134 13,666,446
Accumulated deficit (27,925,927) (27,213,991) (23,788,684)
Total stockholders' equity (deficit) 4,658,085 (1,350,418) (10,120,054)
Total liabilities and stockholders' equity 6,274,047 26,671 108,545
Series A Preferred Stock [Member]      
Stockholders' equity (deficit)      
Preferred stock value 1,521 1,521
Series B Preferred Stock [Member]      
Stockholders' equity (deficit)      
Preferred stock value 129 129
Series C Preferred Stock [Member]      
Stockholders' equity (deficit)      
Preferred stock value 67 67
Series D Preferred Stock [Member]      
Stockholders' equity (deficit)      
Preferred stock value $ 264 $ 264